Physician profile
Joel Mark Davis
NPI 1689876435
$11,952.63
in general payments reported to CMS, 2019-2025
29 companies · $1,407 in 2025
The $1,407 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,124 · 2020: $908 · 2021: $708 · 2022: $700 · 2023: $3,478 · 2024: $627 · 2025: $1,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,012 · Consulting Fee: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,011.74 |
| Consulting Fee | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $2,697.81 | 2023 | Quantum |
| Pylant Medical | $1,913.78 | 2019-2023 | |
| Wright Medical Technology, INC. | $1,551.49 | 2019-2020 | |
| Stryker Corporation | $1,228.29 | 2019-2025 | Easyfuse, Valor, Hoffmann |
| Orthofix Medical, INC. | $1,122.53 | 2019-2025 | Truelok, Physio-Stim, Cervical-Stim |
| Restor3d, INC. | $817.77 | 2024-2025 | |
| Arthrex, INC. | $691.77 | 2019-2020 | |
| In2bones USA, LLC | $236.01 | 2021-2022 | |
| Ossio INC | $233.17 | 2021 | |
| Bone Support INC. | $185.28 | 2024 | Ceramentbone Void Filler, Cerament G |
| Medline Industries LP | $185.18 | 2021-2023 | |
| Trice Medical, INC. | $163.81 | 2022 | |
| Biotissue Holdings INC. | $147.41 | 2025 | |
| P Bar Medical LLC | $123.38 | 2025 | |
| Horizon Therapeutics Plc | $107.10 | 2022-2023 | Krystexxa |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $58.49 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Maruho Medical, INC. | $56.13 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $52.08 | 2023 | Seglentis |
| Acumed LLC | $50.34 | 2022-2024 | Osteomed, Innate Implant, Acumed |
| Vertex Pharmaceuticals Incorporated | $44.05 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $39.40 | 2023-2025 | Exparel, Iovera |
| Acera Surgical, INC. | $39.26 | 2022 | |
| Polynovo North America LLC | $33.01 | 2024 | Novosorb Btm |
| Depuy Synthes Sales INC. | $32.27 | 2023-2024 | Va-Lcp, Na |
| Organogenesis INC. | $31.62 | 2025 | Simplimax |
| Innovation Technologies INC | $31.17 | 2023 | Irrisept |
| Shockwave Medical, INC | $29.52 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kerecis Limited | $26.83 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Treace Medical Concepts, INC. | $23.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.